Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus.
about
Retargeting Strategies for Oncolytic Herpes Simplex VirusesExploring Reovirus Plasticity for Improving Its Use as Oncolytic VirusOncolytic viruses: finally deliveringEvidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapyOncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia.Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases.Talimogene laherparepvec in the treatment of melanoma.Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.Delivering safer immunotherapies for cancer.NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy.Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer.How to train your oncolytic virus: the immunological sequel.Prospects for combined use of oncolytic viruses and CAR T-cells.Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy.Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer.White paper on microbial anti-cancer therapy and preventionVisualizing Oncolytic Virus-Host Interactions in Live Mice Using Intravital MicroscopyOncolytic virus and PD-1/PD-L1 blockade combination therapy
P2860
Q26765439-2CE46B9F-8E85-4034-A5A7-58C25DC1AAF9Q26771799-6F5461C0-C389-4710-A17E-719818409998Q26772039-BD94B72E-ADCE-43E7-865C-FAACD2795131Q26775030-28518847-364D-46F2-AD2D-823B5F6A16D3Q33551626-024E6E17-95C7-4291-B721-E03FFDAB4ECDQ35812675-51ED6D2C-40BD-41BA-BB4A-0EF455BA487CQ36544212-FFBADB52-E545-4009-8F57-B31F2C51952AQ38656524-275D3C26-492F-4B70-8515-BEE53E4A8D6CQ38799217-BDA3ECD7-D160-4B42-A30E-62A2A72A488FQ39330984-33B92D52-157B-4DD0-8021-5C9E7AFDA8D0Q40115977-939D57B0-E568-4E2F-9613-F03C45D2281BQ40429665-E1A668D7-D5EA-4B70-B432-D31D528DDF28Q40611325-69DFBEFB-55E4-4D91-A216-379CFA7A7E06Q47103891-A6CFEE42-AECF-464D-AAD4-B4741FC14499Q52686341-80C2C8DF-7E1C-4A37-9D61-206AFFD6D977Q54213228-0509E688-1018-4BF1-9A75-1ED958A1BD88Q56898750-7FDC4C53-3F89-436F-A040-DA44CE01AA32Q56991805-31342AEF-84C7-45B0-B771-9461FC03D29EQ57174025-2AFB8046-0BCA-45AA-A88C-FD475E2171AB
P2860
Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus.
@ast
Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus.
@en
Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus.
@en-gb
type
label
Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus.
@ast
Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus.
@en
Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus.
@en-gb
prefLabel
Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus.
@ast
Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus.
@en
Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus.
@en-gb
P2093
P2860
P50
P356
P1154
2-s2.0-84926152614
P1433
P1476
Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus.
@en
P2093
Elizabeth Ilett
Hardev Pandha
Jill Thompson
Kevin Harrington
Matt Coffey
Richard Vile
Shane Zaidi
Timothy Kottke
P2860
P304
P356
10.1038/MT.2014.118
P5530
P577
2014-06-24T00:00:00Z
P5875
P6179
1044930176